Perspective Therapeutics (CATX) Interest Coverage Ratio (2010 - 2026)
Perspective Therapeutics recorded quarterly Interest Coverage Ratio of 269.34 in Q1 2026, up 56.72% quarter-over-quarter from 622.38 in Q4 2025, and down 57.91% year-over-year from 639.99 in Q1 2025.
Perspective Therapeutics' Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 269.34 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 57.91% year-over-year to 269.34; the TTM figure through Mar 2026 stood at 339.98 (up 49.88% YoY), while the FY2025 annual figure was 302.03, up 84.05% from the prior year.
- Interest Coverage Ratio came in at 269.34 for Q1 2026 at Perspective Therapeutics, up from 622.38 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 616.22 in Q4 2024 to a low of 696.43 in Q3 2023.
- A 4-year average of 347.36 and a median of 428.63 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 226.66% in 2024 and slumped 201.0% in 2025, its largest moves.
- Perspective Therapeutics' Interest Coverage Ratio stood at 486.5 in 2023, then jumped by 226.66% to 616.22 in 2024, then plunged by 201.0% to 622.38 in 2025, then surged by 56.72% to 269.34 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 269.34, 622.38, and 428.63 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.73 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.09 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.23 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -2.90 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.36 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.98 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | -269.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -269.34 |
| Dec 31, 2025 | -622.38 |
| Sep 30, 2025 | -428.63 |
| Jun 30, 2025 | -202.01 |
| Mar 31, 2025 | -170.56 |
| Dec 31, 2024 | 616.22 |
| Sep 30, 2024 | -270.06 |
| Jun 30, 2024 | -620.13 |
| Mar 31, 2024 | -448.45 |
| Dec 31, 2023 | -486.50 |
| Sep 30, 2023 | -696.43 |
| Jun 30, 2023 | -375.15 |
| Mar 31, 2023 | -542.28 |
| Jun 30, 2016 | -25,080.00 |
| Sep 30, 2015 | -1,148.42 |
| Jun 30, 2015 | 712.17 |
| Mar 31, 2015 | -10,510.12 |
| Sep 30, 2014 | -336.45 |
| Jun 30, 2014 | -23,577.45 |
| Dec 31, 2013 | -12,143.80 |
| Sep 30, 2013 | -1,666.02 |
| Jun 30, 2013 | -1.02 Mn |
| Sep 30, 2012 | -187,134.33 |
| Jun 30, 2012 | -16.99 |
| Mar 31, 2012 | -233.58 |
| Dec 31, 2011 | -267.40 |
| Sep 30, 2011 | -11,726.78 |
| Jun 30, 2011 | -33.17 |
| Mar 31, 2011 | -3.97 |
| Dec 31, 2010 | -44.04 |
| Sep 30, 2010 | -194.60 |